EMDB/PDB/SASBDBから引用されている文献のデータベース

キーワード
構造解析手法	All X線回折 NMR 電子顕微鏡小角散乱中性子線回折線維回折粉末回折赤外分光 EPR FRET 理論モデルハイブリッド
著者・登録者
ジャーナル
IF	>30 >20 >10 >5 all

タイトル	Structural Basis of Nanomolar Inhibition of Tumor-Associated Carbonic Anhydrase IX: X-Ray Crystallographic and Inhibition Study of Lipophilic Inhibitors with Acetazolamide Backbone.
ジャーナル・号・ページ	J. Med. Chem., Vol. 63, Page 13064-13075, Year 2020
掲載日	2020年8月5日 (構造データの登録日)
著者	Andring, J.T. / Fouch, M. / Akocak, S. / Angeli, A. / Supuran, C.T. / Ilies, M.A. / McKenna, R.
リンク	J. Med. Chem. / PubMed:33085484
手法	X線回折
解像度	1.286 - 1.607 Å
構造データ	PDB-7jnr: Carbonic Anhydrase II Complexed with N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)propionamide 手法: X-RAY DIFFRACTION / 解像度: 1.443 Å PDB-7jnv: Carbonic Anhydrase II Complexed with N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)butyramide 手法: X-RAY DIFFRACTION / 解像度: 1.49 Å PDB-7jnw: Carbonic Anhydrase II Complexed with N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)isobutyramide 手法: X-RAY DIFFRACTION / 解像度: 1.292 Å PDB-7jnx: Carbonic Anhydrase II Complexed with N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)pivalamide 手法: X-RAY DIFFRACTION / 解像度: 1.286 Å PDB-7jnz: Carbonic Anhydrase II Complexed with N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)cyclohexanecarboxamide 手法: X-RAY DIFFRACTION / 解像度: 1.289 Å PDB-7jo0: Carbonic Anhydrase IX Mimic Complexed with N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)propionamide 手法: X-RAY DIFFRACTION / 解像度: 1.607 Å PDB-7jo1: Carbonic Anhydrase IX Mimic Complexed with N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)butyramide 手法: X-RAY DIFFRACTION / 解像度: 1.499 Å PDB-7jo2: Carbonic Anhydrase IX Mimic Complexed with N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)isobutyramide 手法: X-RAY DIFFRACTION / 解像度: 1.307 Å PDB-7jo3: Carbonic Anhydrase IX Mimic Complexed with N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)pivalamide 手法: X-RAY DIFFRACTION / 解像度: 1.454 Å PDB-7job: Carbonic Anhydrase IX Mimic Complexed with N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)cyclohexanecarboxamide 手法: X-RAY DIFFRACTION / 解像度: 1.381 Å PDB-7joc: Carbonic Anhydrase IX Mimic Complexed with N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)adamantanecarboxamide 手法: X-RAY DIFFRACTION / 解像度: 1.385 Å
化合物	ChemComp-ZN: Unknown entry ChemComp-VFG: N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)propanamide / 2-(プロピオニルアミノ)-1,3,4-チアジアゾ-ル-5-スルホンアミド ChemComp-GOL: GLYCEROL / グリセロ-ル ChemComp-HOH: WATER ChemComp-VFJ: N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)butanamide / ブタゾルアミド ChemComp-DMS: DIMETHYL SULFOXIDE / 2-チアプロパン2-オキシド / DMSO, 沈殿剤YM ChemComp-VFM: 2-methyl-N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)propanamide / イソブタミド ChemComp-VGS: 2,2-dimethyl-N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)propanamide / N-(5-スルファモイル-1,3,4-チアジアゾ-ル-2-イル)ピバルアミド ChemComp-VGV: N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)cyclohexanecarboxamide ChemComp-ARZ*: (3S,5S,7S)-N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)tricyclo[3.3.1.1~3,7~]decane-1-carboxamide / N-(5-スルファモイル-1,3,4-チアジアゾ-ル-2-イル)アダマンタン-1-カルボアミド
由来	homo sapiens (ヒト)
キーワード	LYASE/INHIBITOR / Carbonic Anhydrase / CA Inhibitor / Structure Guided Drug Design / Carbonic Anhydrase II / Carbonic Anhydrase IX / CAII / CAIX / Sulfonamide / LYASE / LYASE-INHIBITOR complex